No investor complaints for Sheel Biotech in Q2 FY27 quarter

Compliance View source PDF Explain this filing

SHEEL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹60.80

prior close

₹59.55

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.8% vs market

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.1+0.7-2.8

Next day

+2.8-1.0+3.7

—-0.3—

—-1.9—

-1.2-4.5+3.2

-1.2-5.5+4.2

—-7.3—

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Under SEBI LODR Regulation 13(3), Sheel Biotech Limited's Registrar Skyline Financial Services confirmed zero investor complaints for the quarter ended 30 September 2026. No complaints were received, disposed, or remained pending across all sources including SEBI SCORES, ODR portal, and stock exchanges. This is a routine quarterly compliance filing.

Likely market impact

Routine compliance filing with zero complaints suggests no significant investor grievance issues for the quarter.